ScienceTechnical Deep Dive

EQT-Run Scaleup Europe Fund Backs Satellite Startup Iceye

Published
EElectricBuzz Editorial Team
EQT-Run Scaleup Europe Fund Backs Satellite Startup Iceye
1 min read85 wordsElectricBuzz Editorial Team

The Gist

“The EQT-Run Scaleup Europe Fund has invested in Finnish satellite company Iceye Oy, marking its first investment in a strategic technology startup. This move is part of Europe's broader effort to support innovative companies, backed by its €5 billion technology fund.”

The EQT-Run Scaleup Europe Fund's investment in Iceye Oy underscores Europe's commitment to fostering growth in key technology sectors. As a satellite company, Iceye Oy is at the forefront of innovation in space technology.

Key Insights

The investment in Iceye Oy is a significant step for the EQT-Run Scaleup Europe Fund, highlighting its focus on strategic technologies. With Europe's €5 billion technology fund supporting such initiatives, the region is poised to see significant advancements in satellite and space technologies, driven by startups like Iceye Oy.

SPONSORED
The 5 Best Over-Ear ANC Headphones of 2026, Tested & Ranked
Editor's Pick Guide
92/100
Tech & Gadgets•12 min read

The 5 Best Over-Ear ANC Headphones of 2026, Tested & Ranked

We locked five over-ear ANC picks for 2026 — Sony WH-1000XM6, Bose QuietComfort Ultra 2, Soundcore Space One, Sennheiser Momentum 5, and Apple AirPods Max 2 — then stress-tested them on lab metrics, long-term owner truth, and live street prices.

Related Stories

Semantically matched articles, ranked by topic overlap and freshness.

B-Cell Depletion Shows Promise in Early MS Treatment, Study Finds
Science

B-Cell Depletion Shows Promise in Early MS Treatment, Study Finds

A recent comparative study highlights the effectiveness of B-cell-depleting therapies in managing early-stage multiple sclerosis relapses and brain lesions.

Nuclear Medicine Revolutionizes Alzheimer’s Treatment Through Precision Imaging
Science

Nuclear Medicine Revolutionizes Alzheimer’s Treatment Through Precision Imaging

Advanced PET scanning is becoming the cornerstone of Alzheimer's care, allowing clinicians to definitively diagnose the disease and tailor monoclonal antibody therapies to individual patient needs.

The Science of Stress: Why Your Brain Prioritizes Emotional Memories
Science

The Science of Stress: Why Your Brain Prioritizes Emotional Memories

New research from Yale University reveals exactly how the stress hormone cortisol rewires brain connectivity to lock in high-stakes emotional experiences.

Scientists Uncover the Gene That Explains How Exercise Reverses Muscle Aging
Science

Scientists Uncover the Gene That Explains How Exercise Reverses Muscle Aging

A breakthrough study reveals that exercise acts as an internal 'cleanup' crew for aging muscles by regulating a specific gene, potentially unlocking new ways to combat age-related frailty.

Quantum Highways: Atomic-Scale Rails Set to Revolutionize Superconductors
Science

Quantum Highways: Atomic-Scale Rails Set to Revolutionize Superconductors

Researchers in Japan have discovered that atomic-scale steps can guide quantum vortices, potentially paving the way for ultra-efficient, next-generation electronics.

Can Virtual Gardens Cure Nature Deficit? New Research Investigates
Science

Can Virtual Gardens Cure Nature Deficit? New Research Investigates

A groundbreaking study from Drexel University uses virtual reality to reveal how curated ornamental gardens can provide restorative health benefits similar to untouched nature.

Deciphering the Past: Uranium Cubes Reveal Nazi Nuclear Hurdles
Science

Deciphering the Past: Uranium Cubes Reveal Nazi Nuclear Hurdles

New analytical research on surviving uranium artifacts confirms that Nazi Germany's nuclear ambitions were severely crippled by extreme resource shortages and technical limitations.

USC Breakthrough: Scientists Unlock Renewable Source for Next-Gen Cancer Immunotherapy
Science

USC Breakthrough: Scientists Unlock Renewable Source for Next-Gen Cancer Immunotherapy

Researchers have discovered a method to engineer self-renewing immune cell progenitors, paving the way for scalable, 'off-the-shelf' cancer treatments.